QTKPGNGMNYBPSA-UHFFFAOYSA-N
C33H34F3N7O6 — CID 154627624
Data last refreshed: (MolForge compound catalog, from PubChem)
About QTKPGNGMNYBPSA-UHFFFAOYSA-N
QTKPGNGMNYBPSA-UHFFFAOYSA-N (PubChem CID 154627624) has the molecular formula C33H34F3N7O6 and a molecular weight of 681.67 g/mol. Its IUPAC name is tert-butyl 2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-6-[2-[2-[2-(trifluoromethoxy)ethoxy]ethylcarbamoyl]pyrazolo[1,5-a]pyrimidin-6-yl]indol-1-yl]acetate.
Molecular Properties
| Compound Name | QTKPGNGMNYBPSA-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 154627624 |
| Molecular Formula | C33H34F3N7O6 |
| Molecular Weight | 681.67 g/mol |
| Exact Mass | 681.25 |
| IUPAC Name | tert-butyl 2-[3-acetyl-5-(2-methylpyrimidin-5-yl)-6-[2-[2-[2-(trifluoromethoxy)ethoxy]ethylcarbamoyl]pyrazolo[1,5-a]pyrimidin-6-yl]indol-1-yl]acetate |
| SMILES | CC(=O)c1cn(CC(=O)OC(C)(C)C)c2cc(-c3cnc4cc(C(=O)NCCOCCOC(F)(F)F)nn4c3)c(-c3cnc(C)nc3)cc12 |
| InChI | InChI=1S/C33H34F3N7O6/c1-19(44)26-17-42(18-30(45)49-32(3,4)5)28-11-24(23(10-25(26)28)21-13-38-20(2)39-14-21)22-15-40-29-12-27(41-43(29)16-22)31(46)37-6-7-47-8-9-48-33(34,35)36/h10-17H,6-9,18H2,1-5H3,(H,37,46) |
| InChIKey | QTKPGNGMNYBPSA-UHFFFAOYSA-N |
| XLogP | 4.94 |
| TPSA | 151.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 49 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 681.67 |
| LogP ≤ 5 | 4.94 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 12 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'dyes5A(27)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154627624 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.